Literature DB >> 30333145

Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively.

Yihua Wang1,2, Shan Zhong1, Christopher J Schofield3, Peter J Ratcliffe4,5, Xin Lu4.   

Abstract

Hypoxia plays a crucial role at cellular and physiological levels in all animals. The responses to chronic hypoxia are, at least substantially, orchestrated by activation of the hypoxia inducible transcription factors (HIFs), whose stability and subsequent transcriptional activation are regulated by HIF hydroxylases. Factor inhibiting HIF (FIH), initially isolated as a HIFα interacting protein following a yeast two-hybrid screen, is an asparaginyl hydroxylase that negatively regulates transcriptional activation by HIF. This study aimed to define the mechanisms that govern transitions of FIH between the nucleus and cytoplasm. We report that FIH accumulates in the nucleus within a short time window during hypoxia treatment. We provide evidence, based on the application of genetic interventions and small molecule inhibition of the HIF hydroxylases, that the nuclear localization of FIH is governed by two opposing processes: nuclear entry by 'coupling' with HIF1α for importin β1-mediated nuclear import and active export via a Leptomycin B-sensitive exportin1-dependent pathway.This article has an associated First Person interview with the first author of the paper.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  zzm321990FIH; 2-OG; 2-Oxoglutarate; Dioxygenase inhibitors; Factor inhibiting HIF; HIF asparaginyl hydroxylase; Hypoxia; Nuclear translocation

Mesh:

Substances:

Year:  2018        PMID: 30333145      PMCID: PMC6250434          DOI: 10.1242/jcs.219782

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  62 in total

1.  Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway.

Authors:  Charles E Dann; Richard K Bruick; Johann Deisenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

2.  Monoclonal antibody-based screening assay for factor inhibiting hypoxia-inducible factor inhibitors.

Authors:  Sang-Hyeup Lee; Seong-Eon Ryu
Journal:  J Biomol Screen       Date:  2008-06-19

3.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

Authors:  David Lando; Daniel J Peet; Jeffrey J Gorman; Dean A Whelan; Murray L Whitelaw; Richard K Bruick
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

4.  Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].

Authors:  Ineke P Stolze; Ya-Min Tian; Rebecca J Appelhoff; Helen Turley; Charles C Wykoff; Jonathan M Gleadle; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

5.  Selective inhibition of factor inhibiting hypoxia-inducible factor.

Authors:  Michael A McDonough; Luke A McNeill; Melanie Tilliet; Cyril A Papamicaël; Qiu-Yun Chen; Biswadip Banerji; Kirsty S Hewitson; Christopher J Schofield
Journal:  J Am Chem Soc       Date:  2005-06-01       Impact factor: 15.419

6.  5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation.

Authors:  Richard J Hopkinson; Anthony Tumber; Clarence Yapp; Rasheduzzaman Chowdhury; WeiShen Aik; Ka Hing Che; Xuan Shirley Li; Jan B L Kristensen; Oliver N F King; Mun Chiang Chan; Kar Kheng Yeoh; Hwanho Choi; Louise J Walport; Cyrille C Thinnes; Jacob T Bush; Clarisse Lejeune; Anna M Rydzik; Nathan R Rose; Eleanor A Bagg; Michael A McDonough; Tobias Krojer; Wyatt W Yue; Stanley S Ng; Lars Olsen; Paul E Brennan; Udo Oppermann; Susanne Muller-Knapp; Robert J Klose; Peter J Ratcliffe; Christopher J Schofield; Akane Kawamura
Journal:  Chem Sci       Date:  2013-08-01       Impact factor: 9.825

7.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

8.  Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.

Authors:  Rasheduzzaman Chowdhury; José Ignacio Candela-Lena; Mun Chiang Chan; David Jeremy Greenald; Kar Kheng Yeoh; Ya-Min Tian; Michael A McDonough; Anthony Tumber; Nathan R Rose; Ana Conejo-Garcia; Marina Demetriades; Sinnakaruppan Mathavan; Akane Kawamura; Myung Kyu Lee; Freek van Eeden; Christopher W Pugh; Peter J Ratcliffe; Christopher J Schofield
Journal:  ACS Chem Biol       Date:  2013-06-12       Impact factor: 5.100

9.  Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.

Authors:  Ya-Min Tian; Kar Kheng Yeoh; Myung Kyu Lee; Tuula Eriksson; Benedikt M Kessler; Holger B Kramer; Mariola J Edelmann; Carsten Willam; Christopher W Pugh; Christopher J Schofield; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

10.  Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.

Authors:  Ern Yu Tan; Leticia Campo; Cheng Han; Helen Turley; Francesco Pezzella; Kevin C Gatter; Adrian L Harris; Stephen B Fox
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  1 in total

1.  Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis.

Authors:  Christopher J Brereton; Liudi Yao; Elizabeth R Davies; Yilu Zhou; Milica Vukmirovic; Joseph A Bell; Siyuan Wang; Robert A Ridley; Lareb S N Dean; Orestis G Andriotis; Franco Conforti; Lennart Brewitz; Soran Mohammed; Timothy Wallis; Ali Tavassoli; Rob M Ewing; Aiman Alzetani; Benjamin G Marshall; Sophie V Fletcher; Philipp J Thurner; Aurelie Fabre; Naftali Kaminski; Luca Richeldi; Atul Bhaskar; Christopher J Schofield; Matthew Loxham; Donna E Davies; Yihua Wang; Mark G Jones
Journal:  Elife       Date:  2022-02-21       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.